Guido Dallmann

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Individual patients show a large variability in albuminuria response to angiotensin receptor blockers (ARB). Identifying novel biomarkers that predict ARB response may help tailor therapy. We aimed to discover and validate a serum metabolite classifier that predicts albuminuria response to ARBs in patients with diabetes mellitus and micro- or(More)
  • 1